149 related articles for article (PubMed ID: 308099)
1. Evidence that serotonin mediates some behavioral effects of amphetamine.
Sloviter RS; Drust EG; Connor JD
J Pharmacol Exp Ther; 1978 Aug; 206(2):348-52. PubMed ID: 308099
[TBL] [Abstract][Full Text] [Related]
2. Specificity of a rat behavioral model for serotonin receptor activation.
Sloviter RS; Drust EG; Connor JD
J Pharmacol Exp Ther; 1978 Aug; 206(2):339-47. PubMed ID: 682117
[TBL] [Abstract][Full Text] [Related]
3. Exposure to high pressure may produce the 5-HT behavioral syndrome in rats.
Wardley-Smith B; Hudson S; Doré CJ; Charlett A; Fletcher A; Brammer NT; Minchin MC; Wann KT
Undersea Biomed Res; 1990 Jul; 17(4):275-86. PubMed ID: 1697708
[TBL] [Abstract][Full Text] [Related]
4. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
[TBL] [Abstract][Full Text] [Related]
5. Relative potency of amphetamine isomers in causing the serotonin behavioral syndrome in rats.
Sloviter RS; Damiano BP; Connor JD
Biol Psychiatry; 1980 Oct; 15(5):789-96. PubMed ID: 7417631
[TBL] [Abstract][Full Text] [Related]
6. Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine.
Trulson ME; Eubanks EE; Jacobs BL
J Pharmacol Exp Ther; 1976 Jul; 198(1):23-32. PubMed ID: 132525
[TBL] [Abstract][Full Text] [Related]
7. Behavioral correlates of serotonin depletion.
Harvey JA; Schlosberg AJ; Yunger LM
Fed Proc; 1975 Aug; 34(9):1796-801. PubMed ID: 125207
[TBL] [Abstract][Full Text] [Related]
8. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
Lucki I; Nobler MS; Frazer A
J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
[TBL] [Abstract][Full Text] [Related]
9. Effects of short-term serotonin depletion on the efficacy of serotonin neurotransmission: electrophysiological studies in the rat central nervous system.
Chaput Y; Lesieur P; de Montigny C
Synapse; 1990; 6(4):328-37. PubMed ID: 1962911
[TBL] [Abstract][Full Text] [Related]
10. Selective destruction of brain serotonin neurons by 5,7-dihydroxytryptamine increases responding for a conditioned reward.
Fletcher PJ; Korth KM; Chambers JW
Psychopharmacology (Berl); 1999 Dec; 147(3):291-9. PubMed ID: 10639688
[TBL] [Abstract][Full Text] [Related]
11. Para-halogenated phenethylamines: similar serotonergic effects in rats by different mechanisms.
Sloviter RS; Connor JD; Damiano BP; Drust EG
Pharmacol Biochem Behav; 1980 Aug; 13(2):283-6. PubMed ID: 6447879
[TBL] [Abstract][Full Text] [Related]
12. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
Arnt J; Hyttel J; Overø KF
Pol J Pharmacol Pharm; 1984; 36(2-3):221-30. PubMed ID: 6591152
[TBL] [Abstract][Full Text] [Related]
13. Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats.
Miller RT; Lau SS; Monks TJ
Chem Res Toxicol; 1996 Mar; 9(2):457-65. PubMed ID: 8839050
[TBL] [Abstract][Full Text] [Related]
14. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
Lane EL; Brundin P; Cenci MA
Neurobiol Dis; 2009 Jul; 35(1):42-51. PubMed ID: 19361557
[TBL] [Abstract][Full Text] [Related]
15. Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD.
Trulson ME; Ross CA; Jacobs BL
Psychopharmacol Commun; 1976; 2(2):149-64. PubMed ID: 136010
[TBL] [Abstract][Full Text] [Related]
16. Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram.
Arnt J; Overø KF; Hyttel J; Olsen R
Psychopharmacology (Berl); 1984; 84(4):457-65. PubMed ID: 6441945
[TBL] [Abstract][Full Text] [Related]
17. Depletion of brain serotonin following intra-raphe injections of 5,7-dihydroxytryptamine does not alter d-amphetamine self-administration across different schedule and access conditions.
Fletcher PJ; Korth KM; Chambers JW
Psychopharmacology (Berl); 1999 Sep; 146(2):185-93. PubMed ID: 10525754
[TBL] [Abstract][Full Text] [Related]
18. Brainstem serotonergic hyperinnervation modifies behavioral supersensitivity to 5-hydroxytryptophan in the rat.
Pranzatelli MR; Huang YY; Dollison AM; Stanley M
Brain Res Dev Brain Res; 1989 Nov; 50(1):89-99. PubMed ID: 2582610
[TBL] [Abstract][Full Text] [Related]
19. The effects of lesions produced by 5,7-dihydroxytryptamine on 5-hydroxytryptamine-mediated behaviour induced by amphetamine in large doses in the rat.
Dickinson SL; Andrews CD; Curzon G
Neuropharmacology; 1984 Apr; 23(4):423-9. PubMed ID: 6728129
[TBL] [Abstract][Full Text] [Related]
20. Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine.
Avale ME; Nemirovsky SI; Raisman-Vozari R; Rubinstein M
J Neurosci Res; 2004 Oct; 78(2):289-96. PubMed ID: 15378510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
